Dysplastic lesion of unknown severity of the cervix uteri

N14_CERVICAL_DYSPLASIA_NOS

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule only females	313377
2. Check conditions None	313377
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — N87.9 Cause of death: ICD-10 — N87.9 2 out of 7 registries used, show all original rules.	432
4. Check minimum number of events None	432
5. Include endpoints None	432
6. Filter based on genotype QC (FinnGen only)	403

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

First used in FinnGen datafreeze: DF7

NAME	N14_CERVICAL_DYSPLASIA_NOS
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX	2
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	N879
HD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	N879
COD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Dysplastic lesion of unknown severity of the cervix uteri based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	2302	2302	-
Only index persons	2267	2267	-
Unadjusted period prevalence (%)
Whole population	0.07	0.07	-
Only index persons	0.08	0.08	-
Median age at first event (years)
Whole population	-	39.51	-
Only index persons	-	39.34	-

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	403	403	-
Unadjusted period prevalence (%)	0.14	0.14	-
Median age at first event (years)	40.31	40.31	-

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
417: Matched controls
4170

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

N87.9

ICD-10 Finland

Dysplasia of cervix uteri, unspecified

+∞

307.7

417

ULA02

NOMESCO Finland

Kolposcopy

19.9

217.7

295

451

LDA20

NOMESCO Finland

Biopsy of vaginal cervix

16.0

188.0

233

305

LDC03

NOMESCO Finland

Conisation of cervix uteri using diathermy or laser

18.8

184.4

180

162

R87.6

ICD-10 Finland

Abnormal findings in specimens from female genital organs, abnormal cytological findings

12.0

150.3

247

451

LDA10

NOMESCO Finland

Curettage of cervix uteri

13.1

122.3

140

155

XLD00

NOMESCO Finland

Sytologyspecimen from mouth of uterus

9.4

120.9

239

519

N87.2

ICD-10 Finland

Severe cervical dysplasia, not elsewhere classified

14.0

96.6

8077/2-C53.9

ICD-O-3

Squamous intraepithelial neoplasia, high grade of cervix uteri

15.7

88.9

N87.0

ICD-10 Finland

Mild cervical dysplasia

11.4

74.6

N87.1

ICD-10 Finland

Moderate cervical dysplasia

9.9

52.6

A63.0

ICD-10 Finland

Anogenital (venereal) warts

5.2

23.9

114

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

2.3

16.0

234

1475

LEB00

NOMESCO Finland

Biopsy of vagina

6.3

15.8

R87.5

ICD-10 Finland

Abnormal findings in specimens from female genital organs, abnormal microbiological findings

4.8

14.3

SPAT1193

SPAT

Pap smear

2.2

9.2

463

8140/2-C53.9

ICD-O-3

Adenocarcinoma in situ, NOS, of cervix uteri

28.2

8.5

D06.0

ICD-10 Finland

Carcinoma in situ: Endocervix

13.1

8.4

LCA06

NOMESCO Finland

Biopsy of endometrium

2.1

7.9

481

WX704

NOMESCO Finland

Intubation

2.5

7.9

212

WX702

NOMESCO Finland

Supraglottic ventilation device

2.9

7.8

135

R87.9

ICD-10 Finland

Abnormal findings in specimens from female genital organs, unspecified abnormal finding

18.8

7.6

X86

ICPC

Abnormal cervix smear

6.2

7.5

LCD31

NOMESCO Finland

Radical laparoscopic hysterectomy

81.5

7.4

WX725

NOMESCO Finland

Noninvasive ventilation

3.0

7.2

118

ZXC00

NOMESCO Finland

Use of diathermy

12.3

7.1

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.9

6.6

118

SPAT1324

SPAT

Screening procedure

1.8

6.6

139

920

LDB20

NOMESCO Finland

Electrocoagulation or laser therapy of cervix uteri

7.0

6.6

TPH04

NOMESCO Finland

Cathetrisation of vein

2.0

6.5

483

TLW99

NOMESCO Finland

Other minor surgical procedure in gynaecology

3.7

6.4

LFB00

NOMESCO Finland

Biopsy of vulva or perineum

3.5

6.2

LX1AE

NOMESCO Finland

Gynecological ultrasound examination as part of clinical examination

1.9

6.0

535

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3025130) Human papilloma virus identified in Specimen

101

148

8.69

68.99

2.5

1.8

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

132

277

6.51

64.07

2.3

1.6

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

240

1238

3.21

30.16

2.6

1.5

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

141

2.62

6.12

2.4

2.7

85.80

119.01

ng/l

0.30

131

(3019150) Specific gravity of Urine by Refractometry

128

881

1.65

5.04

3.6

3.2

1.02

kg/l

0.74

578

(3019897) Erythrocyte [DistWidth] in Red Blood Cells by Automated count

2.75

4.05

2.2

2.0

13.25

13.21

0.05

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

367

0.36

3.75

1.9

3.8

23.80

32.84

—

274

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

119

918

1.41

2.53

1.3

1.4

19.12

27.22

iu/ml

0.82

293

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

2.51

2.47

6.1

2.0

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

188

1574

1.35

2.41

3.6

3.2

0.00

0.04

estimate

1.63

364

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

3.38

2.40

2.0

1.6

—

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

238

1.70

2.39

1.8

1.4

—

(3002032) Base excess in Venous blood by calculation

225

1.71

2.30

3.6

3.0

2.58

2.05

mmol/l

0.50

195

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

136

1095

1.36

2.20

3.0

2.3

55.64

62.15

u/l

0.68

128

1027

(3029937) Albumin [Presence] in Urine by Test strip

134

1085

1.35

2.08

3.8

3.4

0.00

0.01

estimate

1.08

424

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

4.04

2.04

1.2

1.1

—

(40768804) Tissue Pathology biopsy report

196

1686

1.31

1.97

2.6

2.0

—

(3035350) Ketones [Presence] in Urine by Test strip

234

2066

1.30

1.91

3.8

3.4

26.67

6.69

estimate

0.33

436

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

334

3538

0.72

1.88

10.8

10.4

90.69

90.52

ml/min/173m2

0.06

297

3199

(3026389) Candida sp identified in Specimen by Organism specific culture

2.43

1.86

1.7

1.3

—

(3019225) pH of Specimen

272

0.50

1.84

2.1

3.3

7.36

7.35

—

192

(3001019) Free T4 and TSH panel - Serum or Plasma

395

0.58

1.81

2.0

1.8

—

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

3.08

1.80

1.9

2.3

44.20

50.22

—

(40768793) Breast Pathology biopsy report

154

0.38

1.79

1.3

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

107

857

1.33

1.76

1.3

9.07

14.36

u/ml

0.31

350

(3009261) Glucose [Presence] in Urine by Test strip

234

2080

1.28

1.76

3.7

3.4

0.00

0.02

estimate

1.08

420

(4035726) Immunohistochemistry procedure

269

1.54

1.71

1.4

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

150

1.71

1.67

3.0

2.3

1.98

5.34

ug/l

1.97

133

(3037522) Nuclear Ab [Titer] in Serum

681

1.35

1.66

1.4

573.91

530.77

titre

0.07

156

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

3.03

1.58

2.0

2.3

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

258

1.52

1.57

1.6

—

(3012544) pH of Venous blood

234

1.54

1.55

3.7

3.0

7.37

7.39

0.29

135

(3011288) Drugs identified in Urine by Screen method Nominal

182

0.48

1.55

1.2

1.9

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

2.88

1.51

3.0

3.7

—

(3018418) pH of Serum or Plasma

117

969

1.29

1.50

5.7

3.3

7.39

7.40

0.35

678

(3021601) Nitrite [Presence] in Urine by Test strip

228

2046

1.25

1.48

3.7

3.4

0.00

estimate

0.50

439

(1001926) Buprenorphine [Presence] in Urine by Screen method

212

0.51

1.44

1.4

1.5

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

208

1.53

1.37

1.3

2.50

1.05

u/ml

—

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

300

2795

1.26

1.33

4.3

4.1

9.90

9.51

mm/h

0.27

288

2644

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

111

927

1.27

1.32

2.3

2.1

—

(4024509) Urine culture

153

1.60

1.32

1.8

1.7

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

227

1.49

1.31

1.9

1.7

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

1.88

1.25

1.0

1.1

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

2.42

1.25

2.0

2.2

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

273

1.43

1.23

1.6

1.4

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

449

1.34

1.21

1.6

1.8

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

165

1.55

1.20

1.2

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

898

0.77

1.20

1.7

1.9

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

1.90

1.19

1.1

1.4

—

(3010838) Calcium [Moles/time] in 24 hour Urine

1.90

1.19

1.2

1.8

5.77

5.62

mmol/24h

0.06

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

2.33

1.19

3.8

2.2

515.67

524.45

e6/l

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

310

1.39

1.18

1.5

1.7

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

1.75

1.16

1.3

1.5

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

321

1.38

1.13

1.5

1.6

—

(3019060) Gas panel - Arterial blood

112

1.63

1.10

4.6

4.7

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

357

3696

0.76

1.10

4.6

4.7

2.82

2.86

mmol/l

0.35

340

3539

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

1.75

1.10

1.1

1.4

—

(3000093) Morphology [Interpretation] in Blood Narrative

2.40

1.09

1.2

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

177

1583

1.21

1.09

6.2

5.4

1.22

mmol/l

0.12

158

1374

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

403

1.33

1.09

2.1

2.5

6.56

5.34

umol/l

0.43

347

(3044640) Blood type and Crossmatch panel - Blood

104

1211

0.81

1.06

1.9

2.0

—

(3008898) HLA-B27 [Presence]

239

1.41

1.04

1.1

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

1.86

1.03

1.1

1.4

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

616

1.27

1.03

1.8

2.0

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

644

1.26

1.03

1.7

1.6

432.88

35130868.74

pmol/l

1.05

575

(3028300) Cannabinoids [Presence] in Urine

261

0.64

1.03

1.2

1.6

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

158

1406

1.20

1.01

4.7

4.1

36.58

37.07

g/l

0.56

153

1341

(3027944) Amphetamines [Presence] in Urine

258

0.64

0.98

1.2

1.6

—

(3027008) Opiates [Presence] in Urine

258

0.64

0.98

1.2

1.6

—

(3000764) Benzodiazepines [Presence] in Urine

257

0.65

0.97

1.2

1.6

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

0.00

0.95

0.0

1.3

—

69.28

—

(3048689) Calprotectin [Mass/mass] in Stool

632

1.25

0.95

2.5

2.3

71.34

85.91

ug/g

0.44

497

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

134

1.52

0.93

1.4

1.5

0.01

iu/ml

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

1.84

0.93

1.3

1.4

—

72.48

—

(3023419) Bacteria identified in Sputum by Culture

2.16

0.92

9.3

2.9

—

(3022313) Gas panel - Capillary blood

101

0.49

0.90

3.0

2.9

—

(3016879) Cocaine [Presence] in Urine

240

0.65

0.89

1.3

1.6

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

356

3670

0.80

0.87

4.2

4.3

4.80

4.84

mmol/l

0.37

347

3529

(3007853) Bacteria identified in Skin by Aerobe culture

410

1.28

0.85

1.5

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

410

1.28

0.85

1.7

1.4

—

(44813793) Dust mix specific IgE antibody measurement

1.95

0.84

1.5

1.1

—

(40758558) Short blood count panel - Blood

124

1097

1.19

0.83

5.9

5.8

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

148

1331

1.17

0.82

4.7

3.1

34.00

27.80

u/l

0.75

140

1272

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

1.89

0.82

1.0

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

196

1803

1.16

0.81

5.5

5.6

9.85

9.48

umol/l

0.33

185

1718

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

533

1.24

0.80

3.9

2.3

1.25

0.91

e6/l

0.40

249

(3032700) Glomerular basement membrane Ab [Units/volume] in Serum

0.00

0.78

0.0

1.2

—

(3006571) Granulocytes/Leukocytes in Synovial fluid

0.00

0.77

0.0

1.8

—

42.45

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

388

1.27

0.77

1.9

2.0

3582.53

7260.79

u/l

0.67

172

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

132

1.46

0.77

1.5

2.3

0.65

0.59

0.40

132

(3032080) INR in Blood by Coagulation assay

137

1231

1.17

0.76

6.2

7.4

1.07

1.08

inr

0.06

117

1019

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

518

1.23

0.76

1.6

1.33

0.00

466

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

322

0.73

0.75

1.5

1.14

1.12

ratio

0.03

202

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

322

0.73

0.75

1.5

0.84

0.95

ratio

0.83

202

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

322

0.73

0.75

1.5

1.13

1.19

ratio

0.09

202

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

193

1.37

0.75

1.7

1.6

43.45

55.56

ug/l

1.62

193

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

321

0.73

0.74

1.5

—

(3037756) Immunofixation for Serum or Plasma

1.86

0.74

1.3

1.7

—

(4281824) Cell count and differential, peritoneal fluid

1.86

0.74

1.1

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

100

1.52

0.74

1.3

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

356

3659

0.82

0.73

4.1

4.2

1.53

1.56

mmol/l

0.76

342

3500

(4268621) Lupus anticoagulant assay

1.62

0.73

1.8

2.1

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

1.63

0.72

1.0

1.1

—

(3003694) ABO and Rh group [Type] in Blood

121

1346

0.86

0.72

1.8

1.7

—

(3041096) Erythrocytes [Presence] in Urine by Automated

136

1228

1.16

0.71

2.9

0.00

0.17

estimate

0.63

363

(40768443) Skin Pathology biopsy report

145

0.61

0.70

1.1

1.2

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

117

0.59

0.69

1.4

1.2

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

118

0.59

0.69

1.4

1.2

—

(44790048) Parainfluenza type 2 nucleic acid detection

1.68

0.68

1.1

1.3

—

(44806118) Parainfluenza type 4 nucleic acid detection

1.68

0.68

1.1

1.3

—

(44790049) Parainfluenza type 3 nucleic acid detection

1.68

0.68

1.1

1.3

—

(44790047) Parainfluenza type 1 nucleic acid detection

1.68

0.68

1.1

1.3

—

(3028707) Methadone [Presence] in Urine by Screen method

120

0.58

0.68

1.3

1.7

—

(42529406) Shigella sp [Presence] in Stool by Culture

120

0.58

0.68

1.4

1.3

—

(4062490) Immunoglobulin typing, IgG

1.64

0.67

1.3

1.4

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

285

2720

1.15

0.65

7.8

7.1

74.28

74.54

u/l

0.04

272

2590

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

463

1.22

0.64

1.2

1.3

127.53

150.44

u/ml

0.20

208

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

103

0.58

0.63

1.2

1.4

3.17

3.55

mmol/l

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

133

1456

0.87

0.63

1.7

1.9

97.12

98.88

pmol/l

0.20

791

(21494755) Public health laboratory ask at order entry panel

561

0.82

0.62

1.2

1.3

—

(3035285) Chloride [Moles/volume] in Venous blood

1.67

0.61

1.4

2.5

104.00

106.00

mmol/l

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

1.67

0.61

1.4

2.5

1.22

1.19

mmol/l

—

(3041354) Potassium [Moles/volume] in Venous blood

1.67

0.61

1.4

2.5

4.12

4.01

mmol/l

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

711

1.17

0.61

1.4

1.5

—

(40765089) Chromosome analysis panel - Blood by G-banded

0.00

0.60

0.0

1.0

—

(21494890) Protein electrophoresis panel - 24 hour Urine

0.00

0.60

0.0

2.0

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

1.55

0.59

1.0

1.4

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

0.00

0.59

0.0

1.8

—

(3003329) Lymphocytes/Leukocytes in Synovial fluid

0.00

0.59

0.0

1.9

—

45.59

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

0.00

0.59

0.0

1.2

—

7493.29

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

102

914

1.15

0.59

1.6

1.9

0.76

0.86

mg/l

0.32

703

(3022948) Iron [Moles/volume] in Serum or Plasma

524

1.19

0.59

2.8

2.2

15.53

14.33

umol/l

0.71

488

(1761482) Bacteria [#/volume] in Urine by Culture

1.52

0.58

3.1

4.3

—

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

343

3329

1.17

0.58

16.6

14.5

13.36

13.38

0.10

338

3303

(3007164) IgA [Mass/volume] in Serum or Plasma

997

0.86

0.58

1.5

1.4

2.46

2.15

g/l

0.85

658

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

1.50

0.57

1.2

1.3

182.86

216.88

u/ml

—

(3019977) pH of Arterial blood

257

1.27

0.57

4.7

7.1

7.43

7.41

1.08

142

(3009508) Creatinine [Moles/volume] in Urine

1027

0.87

0.57

4.2

3.0

6.89

7.56

mmol/l

0.83

889

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

324

3339

0.87

0.56

5.5

4.9

37.33

37.42

mmol/mol

0.07

308

3203

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

1.63

0.55

1.0

1.1

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

480

1.19

0.55

2.9

2.2

2.50

2.46

g/l

0.25

440

(3025159) Blasts/Leukocytes in Blood

305

0.77

0.55

3.3

5.0

0.00

0.19

—

(3026008) Bacteria identified in Urine by Culture

123

1122

1.14

0.55

2.9

2.4

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

509

1.19

0.55

1.7

1.8

—

(3003327) Ova and parasites identified in Stool by Light microscopy

193

0.72

0.54

1.5

1.8

—

(3028626) Oxygen [Partial pressure] in Capillary blood

1.49

0.54

2.7

1.9

9.11

8.09

kpa

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

1.50

0.54

1.6

0.00

g/l

-0.00

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

206

1.28

0.52

1.9

1.5

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

1.46

0.52

1.6

1.9

0.00

0.51

g/l

0.93

(3004588) Protein electrophoresis panel - Serum or Plasma

153

1.32

0.51

1.5

2.0

—

(3017181) Myelocytes/Leukocytes in Blood

312

0.79

0.51

3.2

4.5

0.42

1.14

—

(3000991) Gas panel - Venous blood

198

1.28

0.50

5.5

7.2

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

632

0.85

0.50

2.2

2.41

2.42

mmol/l

0.52

571

(3002179) Metamyelocytes/Leukocytes in Blood

300

0.79

0.49

3.3

4.3

0.67

0.96

—

(3045414) Leukocytes [Presence] in Urine

343

0.80

0.49

1.6

1.8

0.33

0.06

estimate

—

(3020961) Endomysium IgA Ab [Titer] in Serum

245

1.24

0.48

1.1

—

195.71

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

196

1852

1.11

0.47

2.5

2.6

—

estimate

—

(3013115) Eosinophils [#/volume] in Blood

217

2063

1.11

0.46

6.1

6.2

0.18

e9/l

0.01

207

1842

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

843

1.13

0.46

2.2

2.0

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

138

1.32

0.46

5.5

2.8

24.28

24.33

mmol/l

0.02

138

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

1.44

0.46

1.1

1.4

—

(3019230) Fractional oxyhemoglobin in Venous blood

1.44

0.46

1.6

2.0

67.43

59.79

—

(3032773) Endomysium IgG Ab [Titer] in Serum

1.44

0.46

1.0

1.1

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

528

1.16

0.45

2.9

3.2

150.94

318.55

ng/l

0.38

286

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

1.41

0.45

1.1

1.3

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

184

1.26

0.44

1.4

2.0

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

1.38

0.44

1.4

1.8

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

1.42

0.43

1.1

1.4

—

(3021589) Normoblasts [#/volume] in Blood

162

1719

0.91

0.43

9.2

9.1

0.00

e9/l

0.81

142

1409

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

0.00

0.41

0.0

1.3

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

0.00

0.41

0.0

1.1

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

0.00

0.41

0.0

2.2

—

1.58

—

(4146454) Self-monitoring of blood glucose

0.00

0.41

0.0

2.7

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

1.36

0.41

1.1

1.4

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

619

1.14

0.41

2.0

1.5

—

(3016750) Collection duration of Urine

0.00

0.40

0.0

2.6

—

519.73

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

1.48

0.40

1.0

1.1

92.00

119.50

pmol/l

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

1.34

0.40

1.6

1.5

—

(42870588) Differential panel, method unspecified - Blood

110

1187

0.90

0.40

6.0

5.8

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

0.00

0.40

0.0

3.7

—

373.89

—

(3015736) pH of Urine

176

1667

1.10

0.39

3.6

3.0

6.28

6.22

0.32

108

973

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

123

1145

1.11

0.39

1.9

1.7

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

133

1.29

0.39

1.4

2.3

1.28

1.19

0.11

133

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

0.00

0.39

0.0

1.1

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

136

0.73

0.38

1.0

1.1

—

(3000850) Epithelial cells [#/volume] in Urine

691

1.12

0.37

4.3

2.4

9.05

9.47

e6/l

0.04

623

(3042936) Bacteria identified in Isolate by Culture

442

1.15

0.37

2.2

1.9

—

(4195642) Thrombophilia screening test

1.27

0.36

1.8

1.2

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

1.47

0.36

1.3

1.2

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

0.65

0.36

1.0

1.3

—

(4094501) Cardiovascular stress test using bicycle ergometer

0.65

0.36

1.4

1.0

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

276

0.82

0.35

1.6

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

379

3735

1.16

0.35

13.0

11.7

21.17

18.70

mg/l

0.72

303

2980

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

425

1.15

0.35

3.3

2.3

25.33

23.11

0.61

394

(3021440) Promyelocytes/Leukocytes in Blood

297

0.83

0.35

3.2

4.6

0.00

0.15

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

1.37

0.34

1.3

1.6

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

1.37

0.34

1.0

1.2

—

(3000494) Fungus identified in Specimen by Culture

454

0.87

0.33

1.4

1.3

—

(3044290) Cell count panel - Cerebral spinal fluid

0.66

0.33

1.0

1.4

—

(40768797) Stomach Pathology biopsy report

495

0.88

0.33

1.1

1.2

—

(36660697) Celiac disease serology panel - Serum

390

0.86

0.33

1.1

1.2

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

630

1.11

0.32

1.8

1.9

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

110

1.28

0.32

1.5

1.3

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

342

3481

0.90

0.31

4.1

5.60

5.65

mmol/l

0.38

322

3300

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

392

3878

1.18

0.30

10.5

10.2

26.36

23.94

u/l

0.56

385

3809

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

130

0.76

0.30

1.3

1.6

—

(3020682) Albumin/Creatinine [Ratio] in Urine

873

0.91

0.29

5.0

3.9

8.03

8.71

mg/mmol

0.07

517

(3018095) Leukocytes [#/volume] in Urine

125

1321

0.92

0.29

5.3

3.3

61.29

54.87

e6/l

0.09

836

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

106

0.75

0.29

2.4

1.8

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

1.30

0.28

1.7

2.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

117

0.76

0.28

1.0

1.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

117

0.76

0.28

1.0

1.1

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

268

0.85

0.27

1.6

1.5

—

(3050129) First trimester maternal screen panel - Serum or Plasma

367

1.13

0.27

1.5

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

0.69

0.26

1.0

1.9

5.24

5.87

pmol/l

—

(3005033) Fetal Nuchal fold Thickness US

266

0.86

0.25

1.5

1.21

1.28

0.30

188

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

1.24

0.25

1.2

1.1

—

(3023368) Bacteria identified in Blood by Culture

712

0.91

0.25

4.0

3.3

—

(3022145) Colonoscopy Study observation

419

1.11

0.23

1.4

1.3

—

(3031040) Bacteria [#/volume] in Urine by Automated count

257

2507

1.07

0.23

5.0

4.1

3397.40

646.97

e6/l

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

200

0.84

0.23

1.1

1.64

1.61

g/l

0.20

200

(3035933) Granulocytes/Leukocytes in Blood

0.75

0.22

1.9

3.6

59.14

59.23

—

(3019069) Monocytes/Leukocytes in Blood

186

1799

1.06

0.22

6.5

5.9

8.10

8.27

0.41

176

1701

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

1.22

0.22

1.0

1.2

—

2737.60

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

262

0.87

0.22

1.7

1.3

269.49

249.26

miu/ml

—

136

(3035637) Corticotropin [Mass/volume] in Plasma

1.19

0.21

1.8

1.4

17.20

22.19

ng/l

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

0.00

0.21

0.0

8.3

—

(4034850) Laboratory test

104

0.76

0.21

12.9

5.6

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

0.00

0.21

0.0

1.3

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

0.00

0.21

0.0

2.5

—

(3006653) Thiamine [Moles/volume] in Blood

0.00

0.21

0.0

1.7

—

153.62

—

(1002224) Polysomnography panel

250

0.87

0.20

1.0

1.1

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

108

1.21

0.20

1.1

1.3

—

1.09

—

(3019309) Folate [Moles/volume] in Red Blood Cells

433

1.10

0.20

1.8

1.6

1244.78

1185.61

nmol/l

0.21

337

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

0.00

0.20

0.0

1.0

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

113

0.79

0.20

1.1

1.3

—

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

279

1.12

0.20

2.1

1.7

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

361

3649

0.92

0.20

5.7

6.0

1.69

1.73

mu/l

0.39

346

3509

(3013139) Helicobacter pylori Ag [Presence] in Stool

308

1.11

0.20

1.2

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

1.20

0.20

1.0

1.1

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

201

1955

1.05

0.19

4.4

4.1

6.30

6.28

mmol/l

0.06

182

1787

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

1.16

0.19

1.8

3.6

13.65

52.43

u/ml

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

493

1.09

0.19

3.7

2.4

4.45

4.70

e6/l

0.07

209

(3004716) Salmonella sp identified in Stool by Organism specific culture

269

0.89

0.18

2.0

1.4

—

(3026493) Urate [Moles/volume] in Serum or Plasma

803

0.93

0.18

2.6

2.2

300.31

296.82

umol/l

0.13

748

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

166

1.15

0.18

1.3

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

153

0.84

0.18

2.1

2.2

—

(3049717) Cytology report of Urine Cyto stain

1.19

0.18

1.4

2.1

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

1.19

0.18

1.7

4.2

59.21

31.48

mg/l

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

1.19

0.18

1.9

4.2

41.61

22.49

mg/l

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

116

1207

0.95

0.17

2.5

3.1

2.34

2.35

mmol/l

0.70

111

1135

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

205

0.87

0.17

1.1

0.82

0.88

g/l

0.60

205

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

111

1155

0.95

0.17

4.7

2.7

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

120

1.17

0.16

1.6

1.7

—

11.42

—

(3000492) Spirometry study

409

1.08

0.16

1.8

1.4

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

1.21

0.15

1.2

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

140

0.85

0.15

1.7

1.5

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

1.14

0.15

1.2

1.5

—

(3022096) Basophils/Leukocytes in Blood

184

1795

1.04

0.15

6.5

5.9

0.65

0.70

0.69

174

1687

(3038177) Helicobacter pylori Ab [Presence] in Serum

1.11

0.15

1.6

1.1

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

360

3631

0.94

0.14

13.5

11.8

139.48

139.65

mmol/l

0.58

355

3560

(3001122) Ferritin [Mass/volume] in Serum or Plasma

224

2283

0.96

0.14

3.4

3.3

74.21

65.49

ug/l

0.57

219

2182

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

279

2749

1.05

0.14

3.0

3.1

40.54

33.79

u/l

0.79

268

2662

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

112

1082

1.05

0.14

2.0

1.8

—

(3006504) Eosinophils/Leukocytes in Blood

184

1799

1.04

0.13

6.2

5.8

2.81

2.76

0.12

174

1697

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

329

3255

1.05

0.13

5.0

14.18

14.33

pmol/l

0.67

313

3094

(3013650) Neutrophils [#/volume] in Blood by Automated count

216

2201

0.96

0.13

8.1

8.8

3.87

3.91

e9/l

0.13

199

1941

(3019198) Lymphocytes [#/volume] in Blood

207

2029

1.04

0.13

6.2

5.9

1.96

1.99

e9/l

0.13

200

1828

(3020891) Body temperature

106

0.85

0.13

6.0

4.0

37.03

36.95

°c

—

106

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

324

0.92

0.13

4.1

2.3

58.32

31.89

u/l

0.64

275

(3012516) Albumin [Mass/volume] in Urine

863

0.95

0.12

4.5

3.3

49.42

46.40

mg/l

0.05

534

(3023103) Potassium [Moles/volume] in Serum or Plasma

361

3637

0.94

0.12

13.6

11.8

3.92

3.90

mmol/l

0.55

356

3550

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

118

1146

1.04

0.12

1.3

0.66

2.05

u/ml

1.73

334

(3023420) DNA double strand Ab [Units/volume] in Serum

201

1.10

0.11

2.7

2.1

10.06

7.33

iu/ml

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

153

1.12

0.11

1.2

1.3

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

961

0.96

0.11

2.3

2.1

2.48

2.58

mg/l

0.25

838

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

1.17

0.11

1.8

1.3

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

115

0.87

0.10

1.3

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

251

1.08

0.10

3.4

4.3

17.66

7.48

ug/l

0.45

195

(40761536) Microorganisms panel - Urine sediment

339

1.07

0.10

3.4

—

(1617658) Protocol used for examination of sentinel lymph nodes

1.09

0.09

1.0

1.1

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

299

0.93

0.09

2.0

2.8

—

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

268

0.93

0.09

2.9

2.3

89.67

76.98

ml/min/173m2

—

116

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

1.04

0.09

1.0

1.7

—

(3021960) Folate [Moles/volume] in Serum or Plasma

904

1.04

0.09

1.5

20.91

21.38

nmol/l

0.12

798

(3025941) Bacteria identified in Stool by Culture

243

1.07

0.09

1.3

1.2

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

1.05

0.08

1.0

1.1

100.50

93.73

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

113

0.88

0.08

2.1

1.9

—

(3019832) Treponema pallidum Ab [Presence] in Serum

877

1.03

0.08

1.7

1.8

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

303

3006

1.03

0.07

3.8

3.9

—

(3002256) Pathology report gross observation

511

1.04

0.07

1.3

1.2

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

114

1117

1.03

0.07

2.9

3.0

88.90

96.35

ng/l

0.03

552

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

0.82

0.07

1.3

1.1

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

0.82

0.07

1.3

1.2

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

285

0.94

0.07

1.1

1.0

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

588

0.96

0.06

1.5

1.8

3.35

3.21

ratio

0.48

450

(3020779) Urea [Moles/volume] in Serum or Plasma

197

1.07

0.06

13.5

7.0

9.20

7.22

mmol/l

0.65

190

(40760892) CBC W Ordered Manual Differential panel - Blood

107

1050

1.03

0.06

3.9

4.2

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

176

1780

0.98

0.05

2.5

72.75

76.15

nmol/l

0.90

165

1674

(3014007) Fractional oxyhemoglobin in Arterial blood

150

0.93

0.04

5.7

8.3

90.93

94.18

0.61

150

(3002030) Lymphocytes/Leukocytes in Blood

188

1863

1.02

0.04

6.2

5.8

30.40

29.61

0.55

180

1779

(3006315) Basophils [#/volume] in Blood

200

1983

1.02

0.04

6.0

5.9

0.04

e9/l

0.36

185

1743

(3037121) Protein [Mass/volume] in Urine

101

1.09

0.04

3.5

3.3

353.83

174.43

mg/l

—

(40761511) CBC panel - Blood by Automated count

389

3901

0.96

0.04

11.6

10.7

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

141

1394

1.02

0.04

7.1

4.8

1.22

mmol/l

0.22

134

1304

(44816559) Phosphatidylethanol [Mass/volume] in Blood

180

1.06

0.04

1.2

1.6

0.31

0.28

mg/l

0.11

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

151

1.06

0.03

1.4

1.5

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

159

0.94

0.03

1.1

1.2

—

1.99

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

169

0.94

0.03

1.9

2.2

2.06

4.48

iu/l

—

(3030467) Casts [#/volume] in Urine by Automated count

902

0.98

0.03

4.7

2.6

0.34

0.35

e6/l

0.01

624

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

344

3451

0.98

0.02

3.4

3.6

1.20

1.19

mmol/l

0.13

329

3282

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

460

0.98

0.02

1.2

1.7

3.16

3.36

mmol/l

0.64

324

(1761868) Lipid panel - Serum or Plasma

172

1729

0.99

0.01

2.5

2.6

—

(3026782) Osmolality of Urine

608

0.98

0.01

3.4

2.5

519.54

509.61

mosm/kgh2o

0.15

533

(3001604) Monocytes [#/volume] in Blood

199

1981

1.01

0.01

6.0

5.8

0.52

e9/l

0.15

185

1746

(3036481) Cortisol [Moles/volume] in Serum or Plasma

393

1.02

0.01

2.1

2.0

375.25

378.54

nmol/l

0.03

373

(46235355) HIV 1 and 2 tests - Meaningful Use set

125

1243

1.01

0.01

2.3

2.1

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

136

0.95

0.00

1.7

1.8

105.85

96.73

0.47

131

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

324

1.02

0.00

6.8

4.7

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

554

1.01

0.00

1.6

998.87

1009.00

mu/l

0.03

459

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

646

0.99

0.00

2.6

3.0

655.63

622.58

ng/l

0.05

533

(3022621) pH of Urine by Test strip

312

0.99

0.00

1.6

2.1

6.35

6.16

0.69

198

(3002582) Erythrocytes [#/volume] in Urine

104

1042

1.00

0.00

5.0

2.7

20.62

88.05

e6/l

1.40

759

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

154

1542

1.00

0.00

1.9

1.8

1.30

1.34

mmol/l

0.31

140

1373

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

291

1.00

0.00

1.3

—

30.53

—

(3023511) Choriogonadotropin [Units/volume] in Urine

205

0.97

0.00

1.4

1.3

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

164

0.97

0.00

1.2

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

0.03

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

0.00

0.0

1.2

—

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

0.00

0.0

2.1

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

0.00

0.0

2.0

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.00

0.0

1.1

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.00

0.0

1.3

—

(3013166) Neutrophils/Leukocytes in Synovial fluid

0.00

0.0

1.3

—

41.12

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

0.00

0.0

1.8

—

(3044009) aPTT.lupus sensitive (LA screen)

0.00

0.0

1.1

—

(3021788) Differential panel - Synovial fluid

0.98

0.00

1.2

1.7

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

0.00

0.0

1.0

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

0.00

0.0

1.7

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

0.00

0.0

2.6

—

(3032057) Clostridioides difficile [Presence] in Stool

0.00

0.0

2.0

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

0.00

0.0

1.2

—

(3019174) dRVVT (LA screen)

0.00

0.0

1.0

—

(3010937) Rubella virus Ab [Presence] in Serum

0.00

0.0

1.1

—

(4133840) Spirometry

0.00

0.0

1.0

—

(3017509) Phencyclidine [Presence] in Urine

0.00

0.0

1.2

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

0.00

0.0

1.2

—

(3051101) Glucose [Moles/volume] in Cord blood

0.00

0.0

2.5

—

6.72

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

0.01

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

0.00

0.0

1.0

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

0.00

0.0

1.3

—

1.18

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.00

-0.00

0.0

1.2

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

0.00

-0.00

0.0

1.2

—

(3004269) Kappa light chains [Mass/time] in 24 hour Urine

0.00

-0.00

0.0

3.4

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.00

-0.00

0.0

1.3

—

(40765096) Chromosome analysis panel by Banding

0.00

-0.00

0.0

1.0

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

0.00

-0.00

0.0

1.1

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

0.00

-0.00

0.0

1.2

—

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

1.6

—

1.82

—

(44806071) Cardiolipin IgM antibody measurement

0.00

-0.00

0.0

1.0

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

0.94

-0.00

1.2

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

0.00

-0.00

0.0

1.9

—

(3020393) Adenovirus Ag [Presence] in Stool

0.00

-0.00

0.0

1.0

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

1.02

-0.00

1.8

1.6

2.52

82.54

u/ml

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

1.00

-0.00

1.3

1.1

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

0.00

-0.00

0.0

2.0

—

44.34

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

0.00

-0.00

0.0

1.4

—

(3004616) Nuclear Ab [Presence] in Serum

1.00

-0.00

1.0

1.2

—

(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

0.04

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

0.00

-0.00

0.0

1.0

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

0.00

-0.00

0.0

1.0

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

0.00

-0.00

0.0

1.3

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

0.00

-0.00

0.0

1.1

—

(37021550) Renin [Units/volume] in Plasma --upright

0.00

-0.00

0.0

1.1

—

132.66

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

0.00

-0.00

0.0

1.6

—

5.55

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

0.00

-0.00

0.0

3.4

—

(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

76.80

—

(3047189) Immunofixation for 24 hour Urine

0.00

-0.00

0.0

2.6

—

(44806420) Estimation of glomerular filtration rate

0.96

-0.00

2.1

2.2

—

(3035715) Granulocytes [#/volume] in Blood

0.96

-0.00

1.9

3.6

4.00

4.49

e9/l

—

(3018010) Neutrophils/Leukocytes in Blood

183

1830

1.00

-0.00

6.1

5.7

55.99

56.50

0.25

177

1759

(3014271) Vancomycin [Susceptibility]

0.00

-0.00

0.0

2.0

—

(1616796) Gas panel - Central venous blood

1.02

-0.00

1.0

2.1

—

(3044941) Cell count panel - Synovial fluid

0.88

-0.00

1.2

1.5

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

0.00

-0.00

0.0

1.1

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

0.85

-0.00

1.4

18.69

35.03

nmol/l

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

0.00

-0.00

0.0

1.8

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

0.00

-0.00

0.0

1.6

—

(3051339) Copper [Moles/volume] in Blood

0.00

-0.00

0.0

1.2

—

15.93

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

0.00

-0.00

0.0

1.4

—

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

2.2

—

30.02

—

(3017569) Oxygen content in Arterial blood

0.00

-0.00

0.0

3.6

—

16.22

—

(3001556) Androgen free Index in Serum or Plasma

0.00

-0.00

0.0

1.1

—

Mortality – FinRegistry

↥

Association

Association between endpoint N14_CERVICAL_DYSPLASIA_NOS and mortality.

Females

Parameter	HR [95% CI]	p-value
N14_CERVICAL_DYSPLASIA_NOS	1.369 [1.07, 1.75]	0.012
Birth year	0.993 [0.98, 1.0]	0.115

During the follow-up period (1.1.1998 — 31.12.2019), 106 out of 1959 females with N14_CERVICAL_DYSPLASIA_NOS died.

Males

No data

Mortality risk

Mortality risk for people of age

years, who have N14_CERVICAL_DYSPLASIA_NOS.

N-year risk	Females	Males
1	0.13%	No data
5	0.761%	No data
10	1.873%	No data
15	3.773%	No data
20	6.533%	No data

Relationships between endpoints

↥

Index endpoint: N14_CERVICAL_DYSPLASIA_NOS – Dysplastic lesion of unknown severity of the cervix uteri

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Dysplastic lesion of unknown severity of the cervix uteri

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints